Literature DB >> 23837023

Myxoid liposarcoma with cartilaginous differentiation: a case study with cytogenetical analysis.

Hyunchul Kim1, Won Hwangbo, Sangjeong Ahn, Suhjin Kim, Insun Kim, Chul Hwan Kim.   

Abstract

Myxoid liposarcoma is a subtype of liposarcoma. This specific subtype can be identified based on its characteristic histological and cytogenetical features. The tumor has a fusion transcript of the CHOP and TLS genes, which is caused by t(12;16)(q13;p11). Most of the fusion transcripts that have been identified fall into three categories, specifically type I (exons 7-2), type II (exons 5-2), and type III (exons 8-2). A total of seven myxoid liposarcomas associated with the rare phenomenon of cartilaginous differentiation have been documented in the literature. Currently, only one of these cases has been cytogenetically analyzed, and the analysis indicated that it was a type II TLS-CHOP fusion transcript in both the typical myxoid liposarcoma and cartilaginous areas. This study presents a second report of myxoid liposarcoma with cartilaginous differentiation, and includes a cytogenetical analysis of both the myxoid and cartilaginous areas.

Entities:  

Keywords:  Cartilage; Cartilaginous differentiation; Heterologous component; Liposarcoma, myxoid; TLS/CHOP fusion transcript

Year:  2013        PMID: 23837023      PMCID: PMC3701826          DOI: 10.4132/KoreanJPathol.2013.47.3.284

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  18 in total

1.  Liposarcoma. A study of 103 cases.

Authors:  F M ENZINGER; D J WINSLOW
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1962

2.  Liposarcoma: a study of 55 cases with a reassessment of its classification.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1979-12       Impact factor: 6.394

3.  Primary myxoid liposarcoma with rhabdomyoblastic differentiation.

Authors:  D Govender; P Pillay
Journal:  Arch Pathol Lab Med       Date:  1998-08       Impact factor: 5.534

4.  Myxoid liposarcoma with cartilaginous differentiation: identification of the same type II TLS-CHOP fusion gene transcript in both lipogenic and chondroid components.

Authors:  Yu-Ching Wei; Chien-Feng Li; Hock-Liew Eng; Ming-Chung Yeh; Ching-Nan Lin; Hsuan-Ying Huang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-12

5.  Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Authors:  M Hisaoka; S Tsuji; Y Morimitsu; H Hashimoto; S Shimajiri; S Komiya; M Ushijima
Journal:  Diagn Mol Pathol       Date:  1998-04

6.  Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma.

Authors:  T A Smith; K A Easley; J R Goldblum
Journal:  Am J Surg Pathol       Date:  1996-02       Impact factor: 6.394

7.  Myxoid liposarcoma with cartilaginous differentiation.

Authors:  J D Siebert; R P Williams; D R Pulitzer
Journal:  Mod Pathol       Date:  1996-03       Impact factor: 7.842

8.  Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11).

Authors:  P Aman; D Ron; N Mandahl; T Fioretos; S Heim; K Arheden; H Willén; A Rydholm; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

9.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.

Authors:  A Crozat; P Aman; N Mandahl; D Ron
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

10.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28
View more
  1 in total

1.  Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Authors:  Kayo Suzuki; Taketoshi Yasuda; Kenta Watanabe; Takeshi Hori; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.